Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause

Albrecht G Schmidt1, Jing Zhai, Andrew N Carr

  • 1Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267-0575, USA.

Cardiovascular Research
|October 24, 2002
PubMed

Insights

Impaired sarcoplasmic reticulum (SR) calcium sequestration due to a phospholamban mutation causes progressive left ventricular dysfunction and heart failure. The phospholamban hinge domain is critical for this process.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Heart Failure Pathophysiology

Background:

  • The sarcoplasmic reticulum (SR) plays a crucial role in cardiac muscle function by regulating intracellular calcium levels.
  • The exact role of SR dysfunction in the development and progression of heart failure remains debated.
  • Phospholamban (PLB) is a key regulator of the SR Ca2+-ATPase (SERCA), influencing calcium reuptake into the SR.

Purpose of the Study:

  • To investigate the hypothesis that impaired SR calcium sequestration is a primary driver of progressive left ventricular (LV) dysfunction.
  • To determine if the phospholamban hinge domain is critical in the process of LV dysfunction and heart failure.
  • To elucidate the molecular mechanisms linking SR function to heart failure progression.

Main Methods:

  • Generation of a phospholamban hinge domain mutant (PLB/N27A) in a phospholamban-null mouse model.
  • Utilized an integrative approach to assess cardiac phenotype at structural, cellular, organ, and whole-animal levels.
  • Employed Nuclear Magnetic Resonance (NMR) for structural analysis and measured SR Ca2+ ATPase activity via oxalate-supported Ca2+ uptake.

Main Results:

  • NMR revealed altered alpha-helical configuration in the mutant phospholamban hinge domain.
  • Mutant phospholamban caused super-inhibition of SR Ca2+ ATPase, impairing calcium sequestration and leading to diastolic dysfunction.
  • Mutant hearts exhibited a blunted force-frequency relation, LV dilation, and progressed to congestive heart failure with depressed systolic function and increased mortality.

Conclusions:

  • Impaired SR calcium sequestration, particularly involving the phospholamban hinge domain, is a causative factor in left ventricular dysfunction and heart failure.
  • The phospholamban hinge domain is crucial for transmitting regulatory signals to SERCA, impacting cardiac contractility and relaxation.
  • These findings highlight a novel mechanism in heart failure pathogenesis and suggest potential therapeutic targets related to SR calcium handling.
Abstract

Related Concept Videos

Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...